Encompass Health (EHC) Stock: Buy, Sell, or Hold?
EHC - Encompass Health Corporation Common Stock
$120.47
-1.20 (-0.99%)
▼
5d:
-4.81%
30d:
-1.87%
90d:
+8.47%
HOLD
MODERATE Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Oct 28, 2026
5d
Get Alerted When EHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: EHC is fairly valued with market pricing in 1.8% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: EHC is fairly valued with market pricing in 1.8% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$157.44
Based on 6.7% avg growth
INTRINSIC VALUE TODAY
$97.76
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EHC is currently trading at $120.47, which is considered slightly low relative to its 30-day fair value range of $120.97 to $124.98. The stock's valuation (Forward PE: 18.0) is in line with its historical norms (17.1). At these levels, the market is pricing in 1.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, EHC is in a strong uptrend. The price is currently testing key support at $119.77. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $148.17 (+23.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EHC is in a strong uptrend. The price is currently testing key support at $119.77. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $148.17 (+23.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$120.97 -
$124.98
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.5%
Protect Your Profits
Holding EHC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (47/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.0% below Wall St target ($148.17)
- NEUTRAL: Market pricing in 1.8% annual earnings growth - fairly valued
- NEUTRAL: Bottoming setup forming (47/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$120.97 -
$124.98
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$119.77
Resistance Level
$129.96
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.04
Wall Street Target
$148.17
(+23.0%)
Revenue Growth (YoY)
9.6%
Earnings Growth (YoY)
10.8%
Profit Margin
10.0%
Valuation Premium vs History
+1.8% premium
PE vs Historical
18.0 vs 17.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.8%
(market-implied from PE analysis)
1-Year Target
$122.64
(+2%)
2-Year Target
$124.85
(+4%)
3-Year Target
$127.09
(+6%)
3-Yr Target (if PE normalizes)
(PE: 18→17)
PE COMPRESSION
$120.48
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 9.3%)
$173.04
(+44%)
Base:
(SPY PE: 18.0, Growth: 9.3%)
$157.18
(+31%)
Bear:
(PE: 15.3, Growth: 9.3%)
$133.60
(+11%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 20.35 | Current EPS (TTM): $5.98
Bull Case
$149.46
(+24%)
Analyst growth 11.7%, PE expands to 22.4
Base Case
$135.88
(+13%)
Market implied 11.7%, PE stable at 20.4
Bear Case
$82.74
(-31%)
Severe decline -20.0%, PE contracts to 17.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 6:29 AM ET
Data refreshes hourly during market hours. Next update: 7:29 AM
Data refreshes hourly during market hours. Next update: 7:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EHC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$286 | 56 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 60 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$461 | 42 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
14 analysts |
$134 | 56 HOLD |
|
GRDN
Guardian Pharmacy Servic… |
STRONG BUY
7 analysts |
$50 | 67 BUY |
Advanced EHC Option Strategies
Professional options setups generated by AI based on today's EHC price and gamma walls.
